Featured Image

RESEARCH STUDY
FOR ALZHEIMER’S DISEASE

Have you or someone you know been diagnosed with Alzheimer’s disease? Consider participating in Athira’s clinical trials.

If you or a loved one has been diagnosed with Alzheimer’s disease, you or they may be eligible to participate in a clinical research study evaluating ATH-1017, a new investigational drug, to see if it is safe and effective in improving symptoms of mild to moderate Alzheimer’s disease. ATH-1017 is designed to boost a repair and regenerative pathway for brain cells, promoting brain health and function.

Clinical Research Professionals in Chesterfield is enrolling adults ages 55 to 85 who have been diagnosed with Alzheimer’s disease to take part in this study.

You or someone you know may be eligible if you/they:

  • Are between 55 and 85 years of age
  • Have been diagnosed with Alzheimer’s disease
  • Have a reliable support person or caregiver who is willing to participate in study visits, report on daily activities and oversee or help you with taking ATH-1017

Study participation and study drug are free to all participants and you may receive a stipend up to $702 to compensate for time and effort for study participation including meals, travel, etc.

Featured Image
To contact the study coordinator, please enter the following information:
Please enter first name.
Please enter last name.
Please enter valid email.
Please enter valid mobile number.
Please enter valid zip code.
Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.